Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05689801

Describe the Effect of the Optimized Hemodialysis Technique (HDx) With Medium Cut-Off Membrane on Recovery Time and Quality of Life

Conditions: Terminal Renal Insufficiency

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 20
Sponsor: Ramsay Générale de Santé

Location: France

Summary

In this study, the effect of optimizing the dialytic technique using simple questionnaires carried out in clinical routine will be described.More specifically, the conventional dialysis technique will be combined with biofeedback software called HemoControl™. The recovery time and quality of life of patients who will use a polyethersulfone membrane (Revaclear®) and a Medium Cut-Off (MCO) membrane (Theranova®) will be observed.The main objective is to describe the evolution of recovery time after a dialysis session in conventional hemodialysis (HD) on Revaclear® membrane and in so-called optimized hemodialysis (HDx) on MCO membrane, Theranova®.

Eligibility Criteria

Inclusion Criteria:Patient, male or female (using contraceptives, if of childbearing age), over 18 years of agePatient on conventional hemodialysis with synthetic membrane for at least 3 monthsPatient with a recovery time after the dialysis session ≥ 4 hoursInformed patient who has signed a written consent to participate in the studyAffiliated patient or beneficiary of a social security schemeExclusion Criteria:Patient whose seniority of dialysis is less than 3 monthsPregnant womanProtected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decisionPatient with severe cognitive impairmentMedically unstable or frail patientPatient who did not sign an informed consent form accepting this research (refusal of consent or absence of signature).

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05689801). StuddyBuddy aggregates publicly available trial information.